Showing results (1111-1120 of 4,821) with videos related to
Sort By:
Pageof 483
BMC Medical Research Methodology|April 23, 2017
Evaluation of the impact of disease prevention measures: a methodological note on defining incidence ratesYin-Bun Cheung, Ying Xu, Matthew Cairns, et al.International Journal of Language & Communication Disorders|July 23, 1998
Evaluating the use of TalksBac, a predictive communication device for nonfluent adults with aphasiaA Waller, F Dennis, J Brodie, et al.Shoulder & Elbow|July 18, 2022
Functional cortical changes associated with shoulder instability - a systematic reviewMorissa F Livett, Deborah Williams, Hayley Potter, et al.Journal of Cancer Research and Clinical Oncology|July 31, 2024
An analysis of the trends in the usage of Pharmaceutical Benefits Scheme-subsidised cancer drugs in Australia from 2012 to 2022Jasmine Lee, Anastasios Panagiotelis, Rose Cairns, et al.Pharmacy (Basel, Switzerland)|December 22, 2023
Pharmacist-Led Interventions for Medication Adherence in Patients with Chronic Kidney Disease: A Scoping ReviewLuke Calleja, Beverley D Glass, Alice Cairns, et al.BMC Cancer|May 11, 2026
A comparison of cancer treatment protocols in Australia, Canada, and the United KingdomJasmine Lee, Anastasios Panagiotelis, Rose Cairns, et al.The New Zealand Medical Journal|December 28, 1983
Deaths from drugs and poisonsF J Cairns, T D Koelmeyer, W M SmeetonPrehospital and Disaster Medicine|September 19, 2014
The 2012 derecho: emergency medical services and hospital responseRandy D Kearns, Mark S Wigal, Antonio Fernandez, et al.Journal of Neural Transmission. Supplementum|January 5, 2002
Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's diseaseB Balcz, L Kirchner, N Cairns, et al.Journal of Neural Transmission. Supplementum|January 5, 2002
Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's diseaseE Engidawork, T Gulesserian, N Balic, et al.Pageof 483